PRIMAEGIS RESEARCH · COMPANY DOSSIER

₹42.0

+15.27% (31 Jul) · Mkt Cap ₹2,170 Cr

52W: ₹19.7 – ₹43.0

ESAF Small Finance Bank

NSE: ESAFSFB · BSE 544020 · Small Finance Bank / Microfinance · Report date: 2026-08-01

NNPA 3.83% → 0.83% in 3 qtrs 3 consecutive profitable quarters Core financing profit still negative ROE −8.86% +113% off the 52w low — recovery priced

Market Cap

₹2,170 Cr

CMP

₹42.0

ROE

−8.86%

FY26 PAT

−₹166 Cr

Jun-26 PAT

₹80 Cr

P/E (ttm)

n/a (loss)

P/B

1.21×

GNPA Jun-26

5.40%

NNPA Jun-26

0.83%

Deposits FY26

₹25,850 Cr

1 · Business — what it sells, to whom

screener.in "about" + key points · company site

Incorporated 1992 (NGO-origin MFI, bank licence 2017; listed Nov-2023). A Kerala-headquartered small finance bank whose franchise is micro loans to low-income and rural customers, now diversifying into mortgages, vehicle, MSME, agri and gold loans, plus para-banking (cards, third-party distribution) and treasury. Distribution is multi-nodal: its own banking outlets, 35 institutional Business Correspondents (who source and service the micro book), and digital channels.

Franchise position

Liability franchise growing: deposits ₹12,815 Cr (FY22) → ₹25,850 Cr (FY26), ~19% CAGR — the deposit engine kept working right through the loss years.
Asset side is the problem: the unsecured micro-loan cycle of FY25 produced the loss; the stated pivot is toward secured lending (mortgages, gold, vehicle).

Moat assessment

Deep rural/BC network — moderate: last-mile reach in Kerala/TN that is costly to replicate.
No pricing moat: microfinance is rate-capped, competitive and cyclical; the moat test is credit underwriting, which FY25 failed.

2 · P&L Quality — 5-year trend & the SETL test

screener.in annual P&L · bank format: financing profit / financing margin, not OPM

FY	Revenue ₹Cr	YoY	Financing profit ₹Cr	Fin. margin	Other income ₹Cr	PAT ₹Cr
FY22	1,940	+18.2%	−101	−5%	208	55
FY23	2,854	+47.1%	160	6%	288	302
FY24	3,819	+33.8%	180	5%	442	426
FY25	3,858	+1.0%	−1,105	−29%	472	−521
FY26	3,537	−8.3%	−974	−28%	811	−166
TTM	3,807	—	−876	−23%	864	−5

The SETL test fails. FY26's improvement from −₹521 Cr to −₹166 Cr is not an operating recovery: financing profit was still −₹974 Cr, and the P&L was rescued by other income jumping ₹472 → ₹811 Cr (₹864 Cr TTM — screener itself flags it). In Jun-26, other income of ₹248 Cr sat above a PBT of ₹107 Cr: strip it and the core lending operation lost money. The profit, so far, is treasury-and-fees, not lending.

3 · Balance Sheet

screener.in · bank balance sheet — D/E and working-capital cycle are not meaningful for a deposit-funded lender; the leverage story is deposits, borrowings and net worth

Item ₹Cr	FY24	FY25	FY26
Equity + Reserves (net worth)	2,492	1,949	1,787
Deposits	19,868	23,276	25,850
Borrowings	3,223	1,406	2,753
Investments	5,541	5,995	6,399
Fixed assets + CWIP	208	300	516
Total assets	26,087	27,178	30,868

Net worth eroded ₹705 Cr in two years (₹2,492 → ₹1,787 Cr) — the FY25/FY26 losses came straight out of book value. Book value per share now ₹34.6.
Deposits +11.1% in FY26 even through the loss headlines — the liability franchise held.
Borrowings doubled in FY26 (₹1,406 → ₹2,753 Cr) and CWIP jumped ₹63 → ₹290 Cr — funding mix and capex both worth watching.
Capital adequacy (CRAR) — not available from this source; renders as a dash rather than an estimate. —

4 · Cash Flow

screener.in · for a bank, CFO swings mostly reflect deposit/advance flow timing, not earnings quality — the SPECTRUM test reads differently here

₹Cr	FY22	FY23	FY24	FY25	FY26
Operating cash flow	−584	−571	+1,001	+3,176	−1,960
Investing cash flow	−982	−573	−583	−769	−192
Financing cash flow	+1,259	+399	+235	−1,852	+1,347
Net cash flow	−308	−745	+654	+556	−805

FY25's +₹3,176 Cr CFO alongside a −₹521 Cr loss is the book shrinking (advances not growing while deposits did), and FY26's −₹1,960 Cr CFO with borrowings up ₹1,347 Cr is the book being rebuilt on borrowed and deposit money. Neither is a fraud signal in a bank — but growth restarting before core profitability has returned is exactly the SPECTRUM pattern to keep on the watch list.

5 · Returns

screener.in ratios

Metric	Value	Reading
ROE (latest)	−8.86%	losses on a shrinking book
ROE (3-yr avg)	−4.22%	screener con flag — the cycle wiped three years of returns
ROCE	5.65%	below any cost of funds — value-destructive at current run-rate
Dividend yield	0.0%	payout suspended since FY25 (FY24 payout was 8%)

Direction: Jun-26 annualised (₹80 Cr × 4 on ₹1,787 Cr net worth) would imply ~18% ROE — but that numerator is other-income-dependent (section 2), so treat it as a ceiling scenario, not a trajectory.

6 · Shareholding — the E2E test

screener.in quarterly pattern

	Dec-23	Jun-24	Dec-24	Jun-25	Dec-25	Mar-26	Jun-26
Promoters	63.39%	63.39%	63.36%	63.31%	63.29%	63.28%	63.25%
FIIs	1.16%	0.12%	0.16%	0.16%	0.01%	0.01%	0.31%
DIIs	10.98%	8.90%	5.02%	5.00%	4.97%	4.63%	3.80%
Public	24.48%	27.57%	31.45%	31.51%	31.74%	32.08%	32.63%
Shareholders	94,713	1,07,413	1,18,512	1,16,490	1,11,691	1,09,246	1,07,631

Promoter 63.25%, effectively steady (−14bp over eleven quarters) — passes the E2E test; no promoter selling into the rally. Pledge — not reported by this source. —
Institutions have left: DIIs 10.98% → 3.80% since listing, FIIs at 0.31% — the recovery has been bought by the public (24.5% → 32.6%), not by institutions. Smart-money validation is absent.

7 · Valuation — what the price assumes

peer figures scraped from screener.in on 01-Aug-2026 · P/E n/a for loss-makers

Small finance bank	CMP ₹	P/E	Book value ₹	P/B	ROE %
AU SFB	1,047	27.5	264	3.97	14.3
Equitas SFB	75.2	16.8	53.7	1.40	1.69
Jana SFB	575	16.0	421	1.37	7.63
Ujjivan SFB	71.8	15.4	35.1	2.05	10.8
Suryoday SFB	162	8.97	196	0.83	7.58
Capital SFB	292	8.80	327	0.89	10.1
Utkarsh SFB	14.6	n/a (loss)	15.6	0.94	−40.0
Peer median (profitable six)	—	~16.0	—	1.37	—
ESAF SFB	42.0	n/a (TTM loss)	34.6	1.21	−8.86

ESAF has no earnings to put a multiple on — TTM PAT is −₹5 Cr. At 1.21× a book that just shrank ₹705 Cr, the market is paying near the peer-median P/B for a bank still earning negative core spreads. What the price assumes: Jun-26's ₹80 Cr quarter is a run-rate, not a peak. If it is (₹320 Cr annualised, EPS ~₹6.2), the stock is at ~6.8× forward and cheap against a ~16× peer median; if other income normalises first, there is no E in the P/E at all. The stock is +113% off its ₹19.7 low and 2.3% below its ₹43 high — the repair story is already largely in the price.

8 · Quarterly Cadence — last 8 quarters & the DEEPINDS test

screener.in quarterly results · financing profit is pre-other-income

Quarter	Revenue ₹Cr	Fin. profit ₹Cr	Other inc ₹Cr	PAT ₹Cr	GNPA %	NNPA %
Sep-24	995	−294	40	−190	6.98	2.98
Dec-24	948	−396	114	−211	6.96	2.97
Mar-25	892	−386	145	−183	6.87	2.99
Jun-25	828	−304	195	−81	7.48	3.77
Sep-25	820	−301	145	−116	8.54	3.83
Dec-25	894	−260	269	+7	5.64	2.73
Mar-26	995	−174	201	+24	5.41	1.77
Jun-26	1,098	−141	248	+80	5.40	0.83

Two honest readings coexist. The asset-quality repair is genuine and fast: GNPA 8.54% → 5.40% and NNPA 3.83% → 0.83% in three quarters — heavy provisioning and clean-up that a bank cannot fake in the NNPA line. And three consecutive profitable quarters (₹7 → ₹24 → ₹80 Cr) with revenue re-accelerating (+32.6% YoY in Jun-26). But the DEEPINDS caveat: financing profit has now been negative for eight straight quarters, and each "profitable" quarter's PAT is smaller than its other-income line. The trend in core (−396 → −141) is real improvement — the crossover to positive core spread is the single number that decides whether this is a turnaround or an other-income bridge.

Guidance & Scenario Block

is_guidance.py / is_scenario.py · guidance context 2026-07-31

Management guidance

No quantitative guidance provided — the guidance corpus carries no ROA/NIM/credit-growth number for NSE:ESAFSFB (guidance status: no_data; management record tag: consistent). No EPS bridge can be built without a guided anchor, so none is printed. No guidance coverage.

Scenario block

Scenario skipped for thin inputs — the model declined to score bear/base/bull EPS paths (collapsed base year: TTM EPS −₹0.1). No targets, no "priced-in" line; printing one would be an estimate, which this dossier does not do. No scenario.

⚡ 9 · VIEW THESIS

Research Reference Only — Not an Investment Recommendation

What you'd have to believe to own it

That the balance-sheet repair (NNPA 0.83%, provisioning done) converts into a positive core lending spread within the next two-to-three quarters, as the improving financing-profit trend (−₹396 → −₹141 Cr) crosses zero and the secured-book pivot holds; that Jun-26's ₹80 Cr PAT is closer to a run-rate than a peak; and that a steady 63.25% promoter plus a deposit franchise that grew 11% through the crisis carry the bank to a normalised mid-teens ROE — at which point today's 1.21× book is inexpensive against peers at ~16× earnings. What breaks it: the microfinance cycle re-flaring (the whole FY25 loss was one cycle), other income normalising before core profitability arrives (leaving no E at all), borrowings-funded regrowth outpacing the repaired underwriting, or a capital raise into a ₹1,787 Cr net worth diluting the recovery. The institutional exit (DII 10.98% → 3.80%) says the professionals are not yet believers; the +113% move off ₹19.7 says the public already is.

Pros (feeds the weekly strip)

Genuine asset-quality repair: GNPA 8.54→5.40%, NNPA 3.83→0.83% in three quarters
Three consecutive profitable quarters, PAT accelerating ₹7 → ₹24 → ₹80 Cr
Core financing loss narrowing every quarter (−₹396 → −₹141 Cr)
Deposits +11.1% FY26 — liability franchise intact through the loss years
Promoter steady at 63.25%; no selling into the rally
P/B 1.21× vs profitable-peer median 1.37× despite the recovery

Cons

Core financing profit negative for 8 straight quarters — the "profit" rides on other income (₹864 Cr TTM vs PBT −₹12 Cr)
FY25 −₹521 Cr and FY26 −₹166 Cr; ₹705 Cr of book value destroyed
ROE −8.86%, ROCE 5.65% — below cost of capital
DIIs 10.98% → 3.80%, FII 0.31% — institutions absent from the recovery
₹42 vs 52w ₹19.7–43 — recovery largely priced, 2.3% under the high
No TTM earnings → no P/E; no management guidance to anchor a forecast

Primaegis Research · Internal Analyst View

WATCH — TURNAROUND UNPROVEN

Conviction: Low-Medium · Horizon: 2–3 quarters of evidence needed

Would change if: quarterly financing profit turns positive (upgrades the thesis), or NPAs re-inflect / other income drops while core is still negative (kills it)

This is an internal, unregulated analytical opinion for research-pipeline use only. It does NOT constitute a SEBI-regulated investment recommendation, research report, or solicitation to buy, sell, or hold any security.

⚠️ IMPORTANT DISCLAIMER
This document is a research and educational output only, generated by the Primaegis Research pipeline. No contributor to this report is a SEBI registered investment advisor or research analyst. Nothing here constitutes investment advice, a research recommendation, or a solicitation to buy, sell, or hold any security under SEBI (Research Analyst) Regulations, 2014 or any other applicable law. All financial data is sourced from publicly available disclosures (screener.in, NSE/BSE filings, company releases); figures that could not be sourced are shown as a dash, never estimated. Street-chatter check: latest Telegram intel corpus reviewed — no mention of this company. Notion publish skipped (headless run). Always conduct your own due diligence and consult a SEBI registered investment advisor before making any financial decision.
Generated: 2026-08-01 | Primaegis Research · Not for distribution.